181 related articles for article (PubMed ID: 31917684)
1. Graft-versus-host disease reduces lymph node display of tissue-restricted self-antigens and promotes autoimmunity.
Dertschnig S; Evans P; Santos E Sousa P; Manzo T; Ferrer IR; Stauss HJ; Bennett CL; Chakraverty R
J Clin Invest; 2020 Apr; 130(4):1896-1911. PubMed ID: 31917684
[TBL] [Abstract][Full Text] [Related]
2. Peripheral antigen display by lymph node stroma promotes T cell tolerance to intestinal self.
Lee JW; Epardaud M; Sun J; Becker JE; Cheng AC; Yonekura AR; Heath JK; Turley SJ
Nat Immunol; 2007 Feb; 8(2):181-90. PubMed ID: 17195844
[TBL] [Abstract][Full Text] [Related]
3. Loss of lymph node fibroblastic reticular cells and high endothelial cells is associated with humoral immunodeficiency in mouse graft-versus-host disease.
Suenaga F; Ueha S; Abe J; Kosugi-Kanaya M; Wang Y; Yokoyama A; Shono Y; Shand FH; Morishita Y; Kunisawa J; Sato S; Kiyono H; Matsushima K
J Immunol; 2015 Jan; 194(1):398-406. PubMed ID: 25422510
[TBL] [Abstract][Full Text] [Related]
4. Emergence of T cells that recognize nonpolymorphic antigens during graft-versus- host disease.
Rangarajan H; Yassai M; Subramanian H; Komorowski R; Whitaker M; Gorski J; Drobyski WR
Blood; 2012 Jun; 119(26):6354-64. PubMed ID: 22496151
[TBL] [Abstract][Full Text] [Related]
5. Lymph node fibroblastic reticular cells directly present peripheral tissue antigen under steady-state and inflammatory conditions.
Fletcher AL; Lukacs-Kornek V; Reynoso ED; Pinner SE; Bellemare-Pelletier A; Curry MS; Collier AR; Boyd RL; Turley SJ
J Exp Med; 2010 Apr; 207(4):689-97. PubMed ID: 20308362
[TBL] [Abstract][Full Text] [Related]
6. Impaired thymic expression of tissue-restricted antigens licenses the de novo generation of autoreactive CD4+ T cells in acute GVHD.
Dertschnig S; Hauri-Hohl MM; Vollmer M; Holländer GA; Krenger W
Blood; 2015 Apr; 125(17):2720-3. PubMed ID: 25691159
[TBL] [Abstract][Full Text] [Related]
7. One-two punch injury to tolerance mechanisms in graft-versus-host disease.
Carrington LJ; Maillard I
J Clin Invest; 2020 Apr; 130(4):1625-1628. PubMed ID: 32149731
[TBL] [Abstract][Full Text] [Related]
8. Infiltrating T cells during liver graft-versus-host disease show a restricted T-cell repertoire.
Margolis DA; Casper JT; Segura AD; Janczak T; McOlash L; Fisher B; Miller K; Gorski J
Biol Blood Marrow Transplant; 2000; 6(4):408-15. PubMed ID: 10917576
[TBL] [Abstract][Full Text] [Related]
9. Fibroblastic niches prime T cell alloimmunity through Delta-like Notch ligands.
Chung J; Ebens CL; Perkey E; Radojcic V; Koch U; Scarpellino L; Tong A; Allen F; Wood S; Feng J; Friedman A; Granadier D; Tran IT; Chai Q; Onder L; Yan M; Reddy P; Blazar BR; Huang AY; Brennan TV; Bishop DK; Ludewig B; Siebel CW; Radtke F; Luther SA; Maillard I
J Clin Invest; 2017 Apr; 127(4):1574-1588. PubMed ID: 28319044
[TBL] [Abstract][Full Text] [Related]
10. Accelerated onset and increased severity of acute graft-versus-host disease following adoptive transfer of DR6-deficient T cells.
Liu J; Heuer JG; Na S; Galbreath E; Zhang T; Yang DD; Glasebrook A; Song HY
J Immunol; 2002 Oct; 169(7):3993-8. PubMed ID: 12244201
[TBL] [Abstract][Full Text] [Related]
11. Acute Graft-versus-Host Disease: Novel Biological Insights.
Teshima T; Reddy P; Zeiser R
Biol Blood Marrow Transplant; 2016 Jan; 22(1):11-6. PubMed ID: 26453971
[TBL] [Abstract][Full Text] [Related]
12. Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis.
Slavin S; Nagler A; Varadi G; Or R
Exp Hematol; 2000 Jul; 28(7):853-7. PubMed ID: 10907647
[TBL] [Abstract][Full Text] [Related]
13. TNF-TNFR2 interactions are critical for the development of intestinal graft-versus-host disease in MHC class II-disparate (C57BL/6J-->C57BL/6J x bm12)F1 mice.
Brown GR; Lee E; Thiele DL
J Immunol; 2002 Mar; 168(6):3065-71. PubMed ID: 11884480
[TBL] [Abstract][Full Text] [Related]
14. Monogenic Immune Diseases Provide Insights Into the Mechanisms and Treatment of Chronic Graft-Versus-Host Disease.
Rozmus J
Front Immunol; 2020; 11():574569. PubMed ID: 33613511
[TBL] [Abstract][Full Text] [Related]
15. Induced SHIP deficiency expands myeloid regulatory cells and abrogates graft-versus-host disease.
Paraiso KH; Ghansah T; Costello A; Engelman RW; Kerr WG
J Immunol; 2007 Mar; 178(5):2893-900. PubMed ID: 17312133
[TBL] [Abstract][Full Text] [Related]
16. Chronic graft-versus-host-disease in CD34(+)-humanized NSG mice is associated with human susceptibility HLA haplotypes for autoimmune disease.
Sonntag K; Eckert F; Welker C; Müller H; Müller F; Zips D; Sipos B; Klein R; Blank G; Feuchtinger T; Schumm M; Handgretinger R; Schilbach K
J Autoimmun; 2015 Aug; 62():55-66. PubMed ID: 26143958
[TBL] [Abstract][Full Text] [Related]
17. Intestinal graft-versus-host disease is initiated by donor T cells distinct from classic cytotoxic T lymphocytes.
Thiele DL; Eigenbrodt ML; Bryde SE; Eigenbrodt EH; Lipsky PE
J Clin Invest; 1989 Dec; 84(6):1947-56. PubMed ID: 2531761
[TBL] [Abstract][Full Text] [Related]
18. Neutrophils provide cellular communication between ileum and mesenteric lymph nodes at graft-versus-host disease onset.
Hülsdünker J; Ottmüller KJ; Neeff HP; Koyama M; Gao Z; Thomas OS; Follo M; Al-Ahmad A; Prinz G; Duquesne S; Dierbach H; Kirschnek S; Lämmermann T; Blaser MJ; Fife BT; Blazar BR; Beilhack A; Hill GR; Häcker G; Zeiser R
Blood; 2018 Apr; 131(16):1858-1869. PubMed ID: 29463561
[TBL] [Abstract][Full Text] [Related]
19. Graft-versus-host disease: an alternative hypothesis.
Parkman R
Immunol Today; 1989 Nov; 10(11):362-4. PubMed ID: 2692593
[TBL] [Abstract][Full Text] [Related]
20. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution.
Gendelman M; Yassai M; Tivol E; Krueger A; Gorski J; Drobyski WR
Biol Blood Marrow Transplant; 2003 Dec; 9(12):742-52. PubMed ID: 14677113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
